← Back to Search

subjects presenting to the emergency room for Bleeding

N/A
Waitlist Available
Led By Jennifer Burris, M.D.
Research Sponsored by Methodist Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the 1st of november 2021 through 1st of july 2024
Awards & highlights
No Placebo-Only Group

Summary

Evidence suggests that the rate of treatable vascular injury is increasing due to improved pre-hospital strategies. The increased rate of vascular trauma occurs in an era of increased sub-specialization, shifting training paradigms and the emergence of endovascular therapies. These factors, in combination with the baseline complexity of vascular trauma, make it particularly important that the management of this injury pattern be evidence-based. However, because all forms and distributions of vascular injury represent only 4% to 9% of trauma admissions, meaningful study of one injury pattern, patient population, therapeutic or surveillance strategy is difficult at a single institution. Further complicating such efforts is the fact that vascular trauma is managed by a wide range of surgical and now endovascular specialists, further fragmenting even a busy trauma institution's experience with vascular injury.

Eligible Conditions
  • Bleeding

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the 1st of november 2021 through 1st of july 2024
This trial's timeline: 3 weeks for screening, Varies for treatment, and the 1st of november 2021 through 1st of july 2024 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
establish an aggregate database

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: subjects presenting to the emergency roomExperimental Treatment1 Intervention
Chart review will include subjects presenting to the emergency room from the 1st of November 2021 through 1st of July 2024.

Find a Location

Who is running the clinical trial?

Methodist Health SystemLead Sponsor
155 Previous Clinical Trials
4,819,828 Total Patients Enrolled
Jennifer Burris, M.D.Principal InvestigatorMethodist Health System
~0 spots leftby Dec 2024